We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Keros Therapeutics
KROS
$221M
| $1.26M | ﹤0.01% |
31,657
-886
| -3% | -$27.8K |
|
2127
Dole
DOLE
$1.32B
| $1.25M | ﹤0.01% |
101,888
+500
| +0.5% | +$5.77K |
|
2128
FLEX LNG
FLNG
$1.67B
| $1.25M | ﹤0.01% |
42,953
+75
| +0.2% | +$2.25K |
|
2129
TTEC Holdings
TTEC
$124M
| $1.24M | ﹤0.01% |
57,037
+662
| +1% | +$13.9K |
|
2130
Zentalis Pharmaceuticals
ZNTL
$302M
| $1.22M | ﹤0.01% |
80,800
-70
| -0.1% | -$1.02K |
|
2131
FuelCell Energy
FCEL
$1.63B
| $1.22M | ﹤0.01% |
25,478
+713
| +3% | +$27.3K |
|
2132
Royal Bank of Canada
RY
$293B
| $1.22M | ﹤0.01% |
12,062
-160
| -1% | -$14.1K |
|
|
LAZR
2133
DELISTED
Luminar Technologies
LAZR
| $1.22M | ﹤0.01% |
24,068
-3
| -0% | -$149 |
|
2134
Gorman-Rupp
GRC
$2.21B
| $1.21M | ﹤0.01% |
34,193
+81
| +0.2% | +$2.61K |
|
2135
4D Molecular Therapeutics
FDMT
$562M
| $1.21M | ﹤0.01% |
59,921
+1,472
| +3% | +$19.4K |
|
2136
FIGS
FIGS
$2.37B
| $1.21M | ﹤0.01% |
173,858
+218
| +0.1% | +$1.44K |
|
|
LPRO
2137
DELISTED
Open Lending Corp
LPRO
| $1.21M | ﹤0.01% |
141,925
-1,277
| -0.9% | -$8.6K |
|
2138
Huazhu Hotels Group
HTHT
$13B
| $1.2M | ﹤0.01% |
35,991
+2,248
| +7% | +$80.4K |
|
2139
Astronics
ATRO
$3.84B
| $1.2M | ﹤0.01% |
82,765
+7,337
| +10% | +$96.2K |
|
|
ACCD
2140
DELISTED
Accolade Inc
ACCD
| $1.2M | ﹤0.01% |
99,871
-2,911
| -3% | -$24.9K |
|
2141
Liquidity Services
LQDT
$1.32B
| $1.2M | ﹤0.01% |
69,607
-1,242
| -2% | -$23.6K |
|
2142
Birkenstock
BIRK
$7.07B
| $1.19M | ﹤0.01% |
+24,507
| New | +$1.06M |
|
2143
Lifestance Health
LFST
$4.14B
| $1.19M | ﹤0.01% |
152,472
-2,597
| -2% | -$16.7K |
|
2144
SI-BONE Inc
SIBN
$834M
| $1.19M | ﹤0.01% |
56,775
+2,870
| +5% | +$53.1K |
|
|
XRN
2145
Chiron Real Estate Inc
XRN
$477M
| $1.19M | ﹤0.01% |
21,405
+85
| +0.4% | +$4.12K |
|
|
NVRO
2146
DELISTED
NEVRO CORP.
NVRO
| $1.18M | ﹤0.01% |
54,930
-146
| -0.3% | -$2.6K |
|
2147
Gray Television
GTN
$552M
| $1.18M | ﹤0.01% |
131,893
+1,873
| +1% | +$13.9K |
|
|
BVH
2148
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $1.18M | ﹤0.01% |
15,726
+637
| +4% | +$37.1K |
|
2149
TETRA Technologies
TTI
$1.26B
| $1.18M | ﹤0.01% |
260,872
+49,910
| +24% | +$252K |
|
2150
Honda
HMC
$41.3B
| $1.17M | ﹤0.01% |
37,982
+106
| +0.3% | +$3.35K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.